Skip to content
value.today

Solstice Biologics LLC

🇺🇸 San Francisco, California, USAPharmaceuticalsFounded 2012
Total raised
$22 M
4 rounds on record
Latest round
$4 M
Dec 2015
First round on record
Nov 2012
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Solstice Biologics LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2015$4 MNo. 4$2 to $10 million

Solstice Biologics LLC: Raise no. 4, Dec 2015

Investors in this round

2 investors had bought by the notice of Dec 30, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-4 Preferred Stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Corey Goodman · Executive Officer, Director, Promoter · Mr. Goodman is the President, Chief Executive Officer and a member of the Board of Managers of the Issuer.
  • Curt Bradshaw · Executive Officer, Director, Promoter · Mr. Bradshaw is the Secretary and Treasurer and a member of the Board of Managers of the Issuer.
  • John Borgeson · Executive Officer · Mr. Borgeson is the Assistant Secretary of the Issuer.
  • George Rehm · Director · Mr. Rehm is a member of the Board of Managers of the Issuer.
  • Robert Adelman · Director · Mr. Adelman is a member of the Board of Managers of the Issuer.
  • Steven Dowdy · Director · Mr. Dowdy is a member of the Board of Managers of the Issuer.

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Corey Goodman, President and CEO of the Issuer. Source: SEC Form D, newest notice filed Dec 30, 2015. Read the notice at the SEC.

equitySEC
Sep 2014$8 MNo. 3$2 to $10 million

Solstice Biologics LLC: Raise no. 3, Sep 2014

Investors in this round

2 investors had bought by the notice of Oct 3, 2014: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Corey Goodman · Executive Officer, Director · Mr. Goodman is President/CEO and Manager of the Issuer.
  • John Borgeson · Executive Officer · Mr. Borgeson is the Assistant Secretary of the Issuer.
  • Curt Bradshaw · Director · Mr. Bradshaw is the Treasurer/Secretary and a Manager of the Issuer.
  • Frank Muhlenbeck · Director · Mr. Muhlenbeck is a Manager of the Issuer.
  • Louis Tartaglia · Director · Mr. Tartaglia is a Manager of the Issuer.
  • Robert Adelman · Director · Mr. Adelman is a Manager of the Issuer.
  • Steven Dowdy · Director · Mr. Dowdy is a Manager of the Issuer.

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series A-3 Units”

Signed by Corey Goodman, President/CEO/Manager. Source: SEC Form D, newest notice filed Oct 3, 2014. Read the notice at the SEC.

equitySEC
Dec 2012$8 MNo. 2$2 to $10 million

Solstice Biologics LLC: Raise no. 2, Dec 2012

Investors in this round

2 investors had bought by the notice of Dec 28, 2012: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Corey Goodman · Executive Officer, Director · Mr. Goodman is President/CEO and Manager of the Issuer.
  • Curt Bradshaw · Director · Mr. Bradshaw is a Manager of the Issuer.
  • Frank Muhlenbeck · Director
  • Robert Adelman · Director · Mr. Adelman is a Manager of the Issuer.
  • Steven Dowdy · Director · Mr. Dowdy is a Manager of the Issuer.

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series A-2 Units”

Signed by Elizabeth von Emster, Assistant Secretary. Source: SEC Form D, newest notice filed Dec 28, 2012. Read the notice at the SEC.

equitySEC
Nov 2012$3 MNo. 1$2 to $10 million

Solstice Biologics LLC: Raise no. 1, Nov 2012

Investors in this round

1 investor had bought by the notice of Dec 12, 2012: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Corey Goodman · Executive Officer, Director · Mr. Goodman is President/CEO and Manager of the Issuer.
  • Curt Bradshaw · Director · Mr. Bradshaw is a Manager of the Issuer.
  • Robert Adelman · Director · Mr. Adelman is a Manager of the Issuer.
  • Steven Dowdy · Director · Mr. Dowdy is a Manager of the Issuer.

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Corey Goodman, President/CEO. Source: SEC Form D, newest notice filed Dec 12, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Solstice Biologics LLC chose not to state its revenue in its newest notice of a funding round (Dec 2015).

    SEC Form D · Dec 2015

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Dec 2015

That is all the official record says: Solstice Biologics LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Solstice Biologics LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 2 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Solstice Biologics LLC
NameRoleNamed in
Corey GoodmanMr. Goodman is the President, Chief Executive Officer and a member of the Board of Managers of the Issuer.Dec 2015
Curt BradshawMr. Bradshaw is the Secretary and Treasurer and a member of the Board of Managers of the Issuer.Dec 2015
John BorgesonMr. Borgeson is the Assistant Secretary of the Issuer.Dec 2015
Corey GoodmanMr. Goodman is the President, Chief Executive Officer and a member of the Board of Managers of the Issuer.Dec 2015
Curt BradshawMr. Bradshaw is the Secretary and Treasurer and a member of the Board of Managers of the Issuer.Dec 2015
George RehmMr. Rehm is a member of the Board of Managers of the Issuer.Dec 2015
Robert AdelmanMr. Adelman is a member of the Board of Managers of the Issuer.Dec 2015
Steven DowdyMr. Dowdy is a member of the Board of Managers of the Issuer.Dec 2015
Frank MuhlenbeckMr. Muhlenbeck is a Manager of the Issuer.Oct 2014
Louis TartagliaMr. Tartaglia is a Manager of the Issuer.Oct 2014
Corey GoodmanMr. Goodman is the President, Chief Executive Officer and a member of the Board of Managers of the Issuer.Dec 2015
Curt BradshawMr. Bradshaw is the Secretary and Treasurer and a member of the Board of Managers of the Issuer.Dec 2015